| William T Mccutchen, MD | |
|
832 Princeton Ave Sw, Birmingham, AL 35211-1320 | |
| (205) 206-8468 | |
| (205) 397-0991 |
| Full Name | William T Mccutchen |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 832 Princeton Ave Sw, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326084633 | NPI | - | NPPES |
| 000085555 | Medicaid | AL | |
| 510-85555 | Other | AL | BCBS OF AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 00006850 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William T Mccutchen, MD Po Box 12366, Birmingham, AL 35202-2366 Ph: (205) 780-7101 | William T Mccutchen, MD 832 Princeton Ave Sw, Birmingham, AL 35211-1320 Ph: (205) 206-8468 |
News Archive
Researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have derived a population of pure lung and thyroid progenitor cells in vitro that successfully mimic the developmental milestones of lung and thyroid tissue formation.
"The House voted overwhelmingly Thursday to eliminate monthly premium increases for millions of Medicare patients next year," The Associated Press reports. "It voted 406 to 18 to send the bill to the Senate, which is expected to act soon. Lawmakers said older Americans shouldn't have to pay higher Medicare Part B premiums because they are not expected to get a cost of living increase from Social Security."
As the demographic shift to an older population continues, a growing number of men and women will be diagnosed with osteoporosis. In addition to existing drug therapies, certain lifestyle and nutritional factors are known to reduce its risk.
Medunik Canada, a Canadian pharmaceutical company specialized in rare diseases, is pleased to announce that PHEBURANE (a tasteless oral formulation of sodium phenylbutyrate), is now available for distribution in Canada. PHEBURANE is the first drug to be approved in Canada for the chronic management of urea cycle disorders (UCD) after receiving market authorisation on January 27th, 2015.
› Verified 2 days ago
Joseph Crivelli, Urology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 | |
Henry Collier Hudson, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 2022 Brookwood Medical Ctr Dr, Suite 510, Birmingham, AL 35209 Phone: 205-250-6061 Fax: 205-250-8957 | |
Charles Peyton, Urology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Jeffrey W Nix, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-945-0254 | |
Lewis K Lloyd, MD Urology Medicare: Medicare Enrolled Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-4011 | |
Joseph Edward Davis Jr., MD Urology Medicare: Medicare Enrolled Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-801-8000 | |
Sunil Sudarshan, Urology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 |